Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas

Clinical Cancer Research

Volumn 9, Issue 12, 2003, Pages 4415-4422

  Girault, Igor ^a   Tozlu, Sengül ^a   Lidereau, Rosette ^a   Bièche, Ivan ^a,b  

^a CENTRE RENÉ HUGUENIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; MESSENGER RNA; TAMOXIFEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC CODE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METHYLATION; NUCLEOTIDE SEQUENCE; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0141995080     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., 72: 141-196, 1998.
2. Robertson, K. D. DNA methylation and chromatin-unraveling the tangled web. Oncogene, 21: 5361-5379, 2002.
3. Hanada, M., Delia, D., Aiello, A., Stadtmauer, E., and Reed, J. C. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood, 82: 1820-1828, 1993.
4. Vilain, A., Vogt, N., Dutrillaux, B., and Malfoy, B. DNA methylation and chromosome instability in breast cancer cell lines. FEBS Lett., 460: 231-234, 1999.
5. Baylin, S. B., Esteller, M., Rountree, M. R., Bachman, K. E., Schuebel, K., and Herman, J. G. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet., 10: 687-692, 2001.
6. Esteller, M., Com, P. G., Baylin, S. B., and Herman, J. G. A gene hypermethylation profile of human cancer. Cancer Res., 61: 3225-3229, 2001.
7. Eads, C. A., Danenberg, K. D., Kawakami, K., Saltz, L. B., Danenberg, P. V., and Laird, P. W. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res., 59: 2302-2306, 1999.
8. El-Deiry, W. S., Nelkin, B. D., Celano, P., Yen, R. W., Falco, J. P., Hamilton, S. R., and Baylin, S. B. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc. Natl. Acad. Sci. USA, 88: 3470-3474, 1991.
9. Kanai, Y., Ushijima, S., Kondo, Y., Nakanishi, Y., and Hirohashi, S. DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int. J. Cancer, 91: 205-212, 2001.
10. Mizuno, S., Chijiwa, T., Okamura, T., Akashi, K., Fukumaki, Y., Niho, Y., and Sasaki, H. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood, 97: 1172-1179, 2001.
11. Patra, S. K., Patra, A., Zhao, H., and Dahiya, R. DNA methyltransferase and demethylase in human prostate cancer. Mol. Carcinog., 33: 163-171, 2002.
12. Robertson, K. D., Uzvolgyi, E., Liang, G., Talmadge, C., Sumegi, J., Gonzales, F. A., and Jones, P. A. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res., 27: 2291-2298, 1999.
13. Saito, Y., Kanai, Y., Sakamoto, M., Saito, H., Ishii, H., and Hirohashi, S. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology, 33: 561-568, 2001.
14. Sato, M., Horio, Y., Sekido, Y., Minna, J. D., Shimokata, K., and Hasegawa, Y. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSFIA in human lung cancer cell lines. Oncogene, 21: 4822-4829, 2002.
15. Vertino, P. M., Yen, R. W., Gao, J., and Baylin, S. B. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase. Mol. Cell. Biol., 16: 4555-4565, 1996.
16. Oue, N., Kuraoka, K., Kuniyasu, H., Yokozaki, H., Wakikawa, A., Matsusaki, K., and Yasui, W. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated: with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas. Oncol. Rep., 8: 1085-1089, 2001.
17. Nass, S. J., Ferguson, A. T., El-Ashry, D., Nelson, W. G., and Davidson, N. E. Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells. Oncogene, 18: 7453-7461, 1999.
18. Bieche, I., Onody, P., Laurendeau, I., Olivi, M., Vidaud, D., Lidereau, R., and Vidaud, M. Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin. Chem., 45: 1148-1156, 1999.
19. Berger, J., and Daxenbichler, G. DNA methylation of nuclear receptor genes-possible role in malignancy. J. Steroid Biochem. Mol. Biol., 80: 1-11, 2002.
20. Esteller, M. Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes. Eur. J. Cancer, 36: 2294-2300, 2000.
21. Domann, F. E., Rice, J. C., Hendrix, M. J., and Futscher, B. W. Epigenetic silencing of maspin gene expression in human breast cancers. Int. J. Cancer, 85: 805-810, 2000.
22. Jackson-Grusby, L., Beard, C., Possemato, R., Tudor, M., Fambrough, D., Csankovszki, G., Dausman, J., Lee, P., Wilson, C., Lander, E., and Jaenisch, R. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat. Genet., 27: 31-39, 2001.
23. Bird, A. P., and Wolffe, A. P. Methylation-induced repression-belts, braces and chromatin. Cell, 99: 451-454, 1999.
24. Fuks, F., Burgers, W. A., Brehm, A., Hughes-Davies, L., and Kouzarides, T. DNA methyltransferase Dnmtl associates with histone deacetylase activity. Nat. Genet., 24: 88-91, 2000.
25. Bhattacharya, S. K., Ramchandani, S., Cervoni, N., and Szyf, M. A. Mammalian protein with specific demethylase activity for mCpG DNA. Nature (Lond.), 397: 579-583, 1999.
26. Bieche, I., Parfait, B., Laurendeau, I., Girault, I., Vidaud, M., and Lidereau, R. Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer. Oncogene, 20: 8109-8115, 2001.
27. Bloom, H. J. G., and Richardson, W. W. Histological grading and prognosis in breast cancer. Br. J. Cancer, 11: 359-377, 1957.
28. Bieche, I., Onody, P., Lerebours, F., Tozlu, S., Hacene, K., Andrieu, C., Vidaud, M., Tubiana-Hulin, M., Spyratos, F., and Lidereau, R. ERBB2 status and benefit from adjuvant tamoxifen in ERalpha-positive postmenopausal breast carcinoma. Cancer Lett., 174: 173-178, 2001.
29. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
30. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
31. Cox, D. R. Regression models and life-tables. J. R. Stat. Soc., 34: 187-220, 1972.
32. Bourc'his, D., Xu, G. L., Lin, C. S., Bollman, B., and Bestor, T. H. Dnmt3L and the establishment of maternal genomic imprints. Science (Wash. DC), 294: 2536-2539, 2001.
33. Lopatina, N., Haskell, J. F., Andrews, L. G., Poole. J. C., Saldanha, S., and Tollefsbol, T. Differential maintenance and de novo methylating activity by three DNA methyltransferases in aging and immortalized fibroblasts. J. Cell. Biochem., 84: 324-334, 2002.
34. Rhee, I., Bachman, K. E., Park, B. H., Jair, K. W., Yen, R. W., Schuebel, K. E., Cui, H., Feinberg, A. P., Lengauer, C., Kinzler, K. W., Baylin, S. B., and Vogelstein, B. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature (Lond.), 416: 552-556, 2002.
35. Lee, P. J., Washer, L. L., Law, D. J., Boland, C. R., Horon, I. L., and Feinberg, A. P. Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. Proc. Natl. Acad. Sci. USA, 93: 10366-10370, 1996.
36. Muller-Tidow, C., Kugler, K., Diederichs, S., Klumpen, S., Moller, M., Vogt, U., Metzger, R., Schneider, P. M., Berdel, W. E., and Serve, H. Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer. Br. J. Cancer, 85: 1168-1174, 2001.
37. Yang, X., Phillips, D. L., Ferguson, A. T., Nelson, W. G., Herman, J. G., and Davidson, N. E. Synergistic activation of functional estrogen receptor (ER)-α by DNA methyltransferase and histone deacetylase inhibition in human ER-α-negative breast cancer cells. Cancer Res., 61: 7025-7029, 2001.